ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Headache,Headaches NEC,Headaches,Nerv,N
1,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
4,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5,1,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
6,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
6,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
6,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
7,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
7,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
8,1,Diabetic foot,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
8,2,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
10,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
11,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
13,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
14,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
14,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
15,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
16,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
16,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
17,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
17,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
18,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
19,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
